Potential of Neural Stem Cells for the Treatment of Brain Tumors

Overview

Journal Clin Med Oncol

Publisher Libertas Academica

Specialty Oncology

Date 2011 Sep 6

PMID 21892316

Authors

P Taupin

Affiliations

Soon will be listed here.

Abstract

Neural stem cells (NSCs) are self-renewing multipotent cells that generate the main phenotypes of the nervous system, neurons, astrocytes and oligodendrocytes. As such they hold the promise to treat a broad range of neurological diseases and injuries. Neural progenitor and stem cells have been isolated and characterized in vitro, from adult, fetal and post-mortem tissues, providing sources of material for cellular therapy. However, NSCs are still elusive cells and remain to be unequivocally identified and characterized, limiting their potential use for therapy. Neural progenitor and stem cells, isolated and cultured in vitro, can be genetically modified and when transplanted migrate to tumor sites in the brain. These intrinsic properties of neural progenitor and stem cells provide tremendous potential to bolster the translation of NSC research to therapy. It is proposed to combine gene therapy and cellular therapy to treat brain cancers. Hence, neural progenitor and stem cells provide new opportunities for the treatment of brain cancers.

References

Aboody K, Brown A, Rainov N, Bower K, Liu S, Yang W . Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A. 2000; 97(23):12846-51. PMC: 18852. DOI: 10.1073/pnas.97.23.12846. View

Cahill D, Kinzler K, Vogelstein B, Lengauer C . Genetic instability and darwinian selection in tumours. Trends Cell Biol. 1999; 9(12):M57-60. View

Kong D, Kim M, Park W, Suh Y, Lee J, Park K . The progression of gliomas is associated with cancer stem cell phenotype. Oncol Rep. 2008; 19(3):639-43. View

Singh S, Clarke I, Terasaki M, Bonn V, Hawkins C, Squire J . Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63(18):5821-8. View

Singh S, Clarke I, Hide T, Dirks P . Cancer stem cells in nervous system tumors. Oncogene. 2004; 23(43):7267-73. DOI: 10.1038/sj.onc.1207946. View

Wu S, Suzuki Y, Noda T, Bai H, Kitada M, Kataoka K . Immunohistochemical and electron microscopic study of invasion and differentiation in spinal cord lesion of neural stem cells grafted through cerebrospinal fluid in rat. J Neurosci Res. 2002; 69(6):940-5. DOI: 10.1002/jnr.10346. View

Vescovi A, Galli R, Reynolds B . Brain tumour stem cells. Nat Rev Cancer. 2006; 6(6):425-36. DOI: 10.1038/nrc1889. View

Kolodny E . Niemann-Pick disease. Curr Opin Hematol. 1999; 7(1):48-52. DOI: 10.1097/00062752-200001000-00009. View

Hemmati H, Nakano I, Lazareff J, Masterman-Smith M, Geschwind D, Bronner-Fraser M . Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A. 2003; 100(25):15178-83. PMC: 299944. DOI: 10.1073/pnas.2036535100. View

10.

Liu Y, Himes B, Solowska J, Moul J, Chow S, Park K . Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus. Exp Neurol. 1999; 158(1):9-26. DOI: 10.1006/exnr.1999.7079. View

11.

Taupin P . The therapeutic potential of adult neural stem cells. Curr Opin Mol Ther. 2006; 8(3):225-31. View

12.

Kondo S . Carcinogenesis in relation to the stem-cell-mutation hypothesis. Differentiation. 1983; 24(1):1-8. DOI: 10.1111/j.1432-0436.1983.tb01294.x. View

13.

Brown A, Yang W, Schmidt N, Carroll R, Leishear K, Rainov N . Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther. 2003; 14(18):1777-85. DOI: 10.1089/104303403322611782. View

14.

Angevine Jr J . Time of neuron origin in the hippocampal region. An autoradiographic study in the mouse. Exp Neurol Suppl. 1965; :Suppl 2:1-70. View

15.

Fujiwara Y, Tanaka N, Ishida O, Fujimoto Y, Murakami T, Kajihara H . Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci Lett. 2004; 366(3):287-91. DOI: 10.1016/j.neulet.2004.05.080. View

16.

Uchida K, Mukai M, Okano H, Kawase T . Possible oncogenicity of subventricular zone neural stem cells: case report. Neurosurgery. 2004; 55(4):977-8. DOI: 10.1227/01.neu.0000137891.99542.43. View

17.

Palmer T, Schwartz P, Taupin P, Kaspar B, Stein S, Gage F . Cell culture. Progenitor cells from human brain after death. Nature. 2001; 411(6833):42-3. DOI: 10.1038/35075141. View

18.

Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G . Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature. 2003; 422(6933):688-94. DOI: 10.1038/nature01552. View

19.

Bai H, Suzuki Y, Noda T, Wu S, Kataoka K, Kitada M . Dissemination and proliferation of neural stem cells on the spinal cord by injection into the fourth ventricle of the rat: a method for cell transplantation. J Neurosci Methods. 2003; 124(2):181-7. DOI: 10.1016/s0165-0270(03)00007-4. View

20.

Potten C, Loeffler M . Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development. 1990; 110(4):1001-20. DOI: 10.1242/dev.110.4.1001. View